← Eichor
Study identifier: NCT05266534 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets

Condition: Myoma  ·  Sponsor: Wael Elbanna Clinic

PhaseNA
Planned participants162
Who can joinFemale, 16 Years to 40 Years
Healthy volunteersNo

About this study

For gynecologists, reaching a conclusion about the efficacy of intramyometrial Terlipressin injection versus intramyometrial Carbetocin injection on hemoglobin level and decreasing blood loss in women undergoing open myomectomy that would influence the clinical decision and best practice. Besides enriching the clinical evidence in open myomectomy without using haemostatic tourniquets. For society, our conclusion and recommendation shall maximize the benefits and managing the benefits of the technique used. Moreover, providing more information for women undergoing open myomectomy without using haemostatic tourniquets.

This description comes directly from the study's public registry record.

Talk to the study team

Wael El Banna  ·  01227760402  ·  waelelbanna@drwaelelbanna.com

Esraa mohammad  ·  01212421260  ·  esraamoghawry@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Wael El Banna ClinicMaadi, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05266534